- Home
- CDNA vs BLFS Comparison
CDNA vs BLFS Comparison
Compare CDNA & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- BLFS
- Stock Information
- Founded
- CDNA 1998
- BLFS 1987
- Country
- CDNA United States
- BLFS United States
- Employees
- CDNA N/A
- BLFS N/A
- Industry
- CDNA Medical Specialities
- BLFS Medical/Dental Instruments
- Sector
- CDNA Health Care
- BLFS Health Care
- Exchange
- CDNA Nasdaq
- BLFS Nasdaq
- Market Cap
- CDNA 944.1M
- BLFS 969.8M
- IPO Year
- CDNA 2014
- BLFS 1989
- Fundamental
- Price
- CDNA $22.79
- BLFS $25.73
- Analyst Decision
- CDNA Buy
- BLFS Strong Buy
- Analyst Count
- CDNA 8
- BLFS 6
- Target Price
- CDNA $27.17
- BLFS $27.50
- AVG Volume (30 Days)
- CDNA 816.5K
- BLFS 527.5K
- Earning Date
- CDNA 11-04-2024
- BLFS 11-12-2024
- Dividend Yield
- CDNA N/A
- BLFS N/A
- EPS Growth
- CDNA N/A
- BLFS N/A
- EPS
- CDNA N/A
- BLFS N/A
- Revenue
- CDNA $312,775,000.00
- BLFS $146,957,000.00
- Revenue This Year
- CDNA $19.60
- BLFS N/A
- Revenue Next Year
- CDNA $10.26
- BLFS $8.56
- P/E Ratio
- CDNA N/A
- BLFS N/A
- Revenue Growth
- CDNA 5.26
- BLFS 16.40
- 52 Week Low
- CDNA $7.42
- BLFS $11.91
- 52 Week High
- CDNA $34.84
- BLFS $28.88
- Technical
- Relative Strength Index (RSI)
- CDNA 42.58
- BLFS 56.08
- Support Level
- CDNA $21.16
- BLFS $19.47
- Resistance Level
- CDNA $24.42
- BLFS $28.88
- Average True Range (ATR)
- CDNA 1.30
- BLFS 1.91
- MACD
- CDNA 0.16
- BLFS -0.06
- Stochastic Oscillator
- CDNA 43.83
- BLFS 62.91
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.